Search for Clinical Trial Results
Carcinoma, Transitional Cell - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Safety and Efficacy of JS001 for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma Condition: Bladder Urothelial Carcinoma Date: 2017-04-06 Interventions: Biological: humanized anti-PD-1 monoclonal antibody humanized anti-PD-1 monoclonal antibody (JS001) is a |
Recruiting |
Study Name: DNA Methylation and Arsenic-associated Urothelial Carcinoma Condition: Urothelial Carcinoma Date: 2011-05-24 |
Recruiting |
Study Name: Study of MPDL3280A in Bladder Cancer Condition: Carcinoma, Transitional Cell Date: 2015-03-04 Interventions:
|
Recruiting |
Study Name: The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study Condition: Carcinoma, Transitional Cell Date: 2016-05-29 Interventions: Drug: MitoGel™ instillations Treatment with MitoGel™ once weekly for a total of 6 times; in |
Recruiting |
Study Name: Tesetaxel for Previously Treated Patients With Bladder Cancer Condition: Carcinoma, Transitional Cell Date: 2010-10-05 Interventions: Drug: Tesetaxel Tesetaxel capsules orally once every 21 da |